On May 9, 2024, Gilead Sciences, Inc announced that it held its annual general meeting of shareholders on May 8, 2024, and declared voting results. Accordingly, a shareholder proposal from John Chevedden, requesting that the Board adopt a policy requiring the Company?s named executive officers to retain at least 25% of net-after tax shares of stock acquired through equity pay programs until reaching normal retirement age (at least age 60) was not approved.